Work

The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

Year: 2014

Type: article

Source: Current Pharmaceutical Design

DOI: 10.2174/1381612820666140901215544

Authors: Sylvain Goutelle, Laurent Bourguignon, Pascal Maire, Roger Jelliffe, Michael Neely

Institution: Hospices Civils de Lyon

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2113953670

FWCI: 1.401

Cites:

Cited by: 13

Related to: 10